Market revenue in 2023 | USD 363.0 million |
Market revenue in 2030 | USD 1,942.1 million |
Growth rate | 27.1% (CAGR from 2023 to 2030) |
Largest segment | Diabetes |
Fastest growing segment | Diabetes |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
Key market players worldwide | Omega Healthcare Investors Inc, Teladoc Health Inc, ResMed Inc, Fitbit, Mango Health, Akili Inc Ordinary Shares, Hygeia Healthcare Holdings Co Ltd Ordinary Shares, DarioHealth Corp, BioGaia AB Class B |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 29.15% in 2023. Horizon Databook has segmented the Canada digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Canada’s market is expected to exhibit lucrative growth in the near future, owing to its advanced healthcare information system, e.g., the Canadian Institute for Health Information (CIHI), which can help raise awareness.
For instance, in January 2019, Health Canada circulated a draft guidance document on Software as a Medical Device (SaMD). These initiatives can help companies enhance their overall efficiency, thus, propelling the market. Furthermore, companies are adopting various strategies to cater to market demand.
In February 2021, Nex Cubed publicized a partnership with the Canadian Government to introduce the SoCal Tech Highway Digital Health Program, which provides the country’s digital health startups a chance to increase their business in the U.S. market.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada digital therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Canada digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account